KATHERINE LITTLE: Open Payments
NPI 1588989230 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 28 payments from 9 companies in 2025. Trend: 2023 $339 · 2024 $694 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $197 |
| Alkermes, Inc. | 3 | $121 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: VRAYLAR, LYBALVI, REXULTI, COBENFY, ARISTADA, UZEDY, INGREZZA, INVEGA SUSTENNA.
Industry payments across LA — which companies pay providers there.
